Daniel J. Haraf

University of Chicago — United States

Medicine · Health Sciences

55h-index10.9kcitations262works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(190), Head and Neck Surgical Oncology(68), Lung Cancer Treatments and Mutations(41), Cancer Diagnosis and Treatment(40), Brain Metastases and Treatment(33)

Publications262 total

Locally Advanced Oral Cavity Cancer Treated with Definitive Chemoradiation: An Organ Preservation Strategy Over Three Decades
International Journal of Radiation Oncology*Biology*Physics·2025
Supplementary Table 1 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Supplementary Figure 1 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Supplemental Table 2 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Supplemental Table 4 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Supplemental Table 3 from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Data from Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
2025Open Access
Circulating tumor HPV-DNA dynamics and neoadjuvant chemotherapy with or without nivolumab in viral-mediated oropharyngeal cancer.
Journal of Clinical Oncology·2025· 1 cited
Functional and survival outcomes in HPV positive oropharyngeal squamous cell cancer treated with response-adaptive de-escalation: A pooled analysis.
Journal of Clinical Oncology·2025
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
Clinical Cancer Research·2025· 4 citedOpen Access
Abstract B023: Cell-free HPV-DNA dynamics during induction chemotherapy and response-stratified de-escalation in viral-mediated oropharyngeal cancer
Clinical Cancer Research·2024
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV<sup>+</sup> Oropharyngeal Cancer
JAMA Oncology·2024· 40 citedOpen Access
A randomized, double-blind, placebo-controlled phase II study of adjuvant pembrolizumab versus placebo in patients with head and neck squamous cell cancers at high risk for recurrence: The PATHWay study.
Journal of Clinical Oncology·2024· 9 cited
Xevinapant with radiation and concurrent carboplatin and paclitaxel in patients ineligible for cisplatin with locoregionally advanced squamous cell carcinoma of the head and neck (EXtRaCT study).
Journal of Clinical Oncology·2024· 1 cited
Neoadjuvant HPV16-specific arenavirus-based immunotherapy HB-200 plus chemotherapy followed by response-stratified de-intensification in HPV16+ oropharyngeal cancer: TARGET-HPV.
Journal of Clinical Oncology·2024· 10 cited
Neutrophil-to-Lymphocyte Ratio Kinetics and Survival with Neoadjuvant Immuno-chemotherapy and Response-Stratified Chemoradiation in Locoregionally Advanced Head and Neck Cancer
International Journal of Radiation Oncology*Biology*Physics·2024
185 Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer
Radiotherapy and Oncology·2024
886P Prospective evaluation of dynamic changes of cell-free HPV-DNA (cfHPV-DNA) in locoregional HPV associated (HPV+) oropharyngeal cancer (OPC) treated with neoadjuvant chemotherapy and response-stratified treatment
Annals of Oncology·2023· 1 citedOpen Access
Involved Site Radiotherapy in HPV Positive Oropharyngeal Cancer: Patterns of Failure Analysis Across Prospective De-Escalation Trials
International Journal of Radiation Oncology*Biology*Physics·2023Open Access
Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx Cancer
International Journal of Radiation Oncology*Biology*Physics·2023· 1 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Everett E. Vokes(47), Kerstin Stenson(20), Ralph R. Weichselbaum(19), Bharat B. Mittal(18), Ezra E.W. Cohen(13), Bruce Brockstein(13), Harold J. Pelzer(11), Marcy A. List(10), Mary Ellyn Witt(10), Merrill S. Kies(10), Joseph K. Salama(9), Alfred Rademaker(8), Victoria Villaflor(7), Fred Rosen(7), Elizabeth A. Blair(7), Athanassios Argiris(7), Tanguy Y. Seiwert(6), Louis Portugal(6), Steven J. Chmura(5), Philip C. Hoffman(5)